Since the introduction of benzylpenicillin in clinical trials about 60 years ago, the effectiveness of penicillins and related compounds (␤-lactam antibiotics) has been continuously challenged by the emergence of resistant pathogenic strains. Although bacteria have developed several strategies for escaping the lethal actions of ␤-lactam antibiotics (13, 31, 42), the most common and often the most efficient mechanism is the synthesis of ␤-lactamases (14, 20, 29, 48) . These enzymes, which are usually secreted into the external medium by gram-positive species and into the periplasm by their gram-negative counterparts, very efficiently catalyze the irreversible hydrolysis of the amide bond of the ␤-lactam ring, yielding biologically inactive products. Despite the large number (ϳ300 [7] ) of ␤-lactamases described to date, these enzymes are divided into only four classes, classes A, B, C, and D, on the basis of their amino acid sequences (35). Enzymes of classes A, C, and D are active-site serine ␤-lactamases, whereas class B enzymes are Zn 2ϩ dependent.
Since the introduction of benzylpenicillin in clinical trials about 60 years ago, the effectiveness of penicillins and related compounds (␤-lactam antibiotics) has been continuously challenged by the emergence of resistant pathogenic strains. Although bacteria have developed several strategies for escaping the lethal actions of ␤-lactam antibiotics (13, 31, 42) , the most common and often the most efficient mechanism is the synthesis of ␤-lactamases (14, 20, 29, 48) . These enzymes, which are usually secreted into the external medium by gram-positive species and into the periplasm by their gram-negative counterparts, very efficiently catalyze the irreversible hydrolysis of the amide bond of the ␤-lactam ring, yielding biologically inactive products. Despite the large number (ϳ300 [7] ) of ␤-lactamases described to date, these enzymes are divided into only four classes, classes A, B, C, and D, on the basis of their amino acid sequences (35) . Enzymes of classes A, C, and D are active-site serine ␤-lactamases, whereas class B enzymes are Zn 2ϩ dependent.
Therefore, much effort has been devoted to the synthesis of molecules which would not be cleaved by ␤-lactamases of pathogenic strains and which have suitable physicochemical and pharmacodynamic profiles. Absolute stability has, however, not been achieved with any one drug. An alternative strategy to the use of these so-called ␤-lactamase-stable compounds rests on the use of two ␤-lactams in synergy: one is an efficient ␤-lactamase inactivator but a poor antibiotic, while the second is a good, but ␤-lactamase-sensitive, antibiotic. The former is able to potentiate the action of the latter by protecting it from enzymatic hydrolysis (31, 43) . Thus, ␤-lactamase inactivators such as clavulanic acid, sulbactam, and tazobactam have been successfully used against bacteria that produce the ubiquitous and prevalent TEM-1 or TEM-2 and SHV-1 class A ␤-lactamases (38) . These "wonder" drugs display, however, little or no activity against class B and C enzymes. In addition, bacterial susceptibility to such combinations has recently been challenged by the spontaneous appearance of new ␤-lactamases of the TEM family, which are resistant to the mechanism-based inactivators (9, 28, 46, 50) .
Recently, by following a rational drug design approach, novel tricyclic carbapenem compounds (12) with potential inhibitory activity against serine ␤-lactamases were synthesized. In this paper we describe the kinetics of the interaction between two of these compounds (Lek 156 and Lek 157; Fig. 1 ) and representative ␤-lactamases of the four classes. Streptomyces sp. strains R61 and K15 D-alanyl-D-alanine peptidases (DD-peptidases), which are prototypes for penicillinbinding proteins (23) , were also studied. The specificities of the interactions of Lek 156 and Lek 157 with active-site serine ␤-lactamases and DD-peptidases, which constitute two closely related families of penicillin-recognizing enzymes (26) , have been determined. The influence of the compounds on the MIC of ampicillin for Enterobacter cloacae P99 was also evaluated.
Ayerst Laboratories (West Chester, Pa.). Nitrocefin was purchased from Unipath (Basingstoke, United Kingdom). Ampicillin was purchased from Sigma Chemical Co. (St. Louis, Mo.). Phenylacetyl-D-alanyl-thio-lactate (S 2 x) was a gift of Hoechst-Marion-Roussel (Romainville, France), and benzoyl-D-alanyl-thioglycolate (S 2 d) was synthesized as described by Adam et al. (1) .
Enzymes. The various enzymes studied in the present work are listed in Table  1 . All enzyme preparations were at least 95% pure.
In vitro susceptibility tests. The MICs of ampicillin were determined in the absence or in the presence of Lek 156 or Lek 157 at final concentrations of 10 or 30 g/ml by a dilution technique with Mueller-Hinton broth and a bacterial inoculum of approximately 5 ϫ 10 5 CFU per tube, according to the guidelines of the National Committee for Clinical Laboratory Standards. The strain tested was E. cloacae P99, a strain which constitutively overproduces a class C ␤-lactamase (19) . The P99 and the Q908 enzymes are virtually identical (24, 25) . A control experiment was also performed in the presence of 10 g of tazobactam per ml.
Experimental conditions for kinetic studies. All kinetic measurements were performed at 30°C. The buffer for ␤-lactamases of classes A and D was 50 mM sodium phosphate (pH 7.0), that for the class C ␤-lactamase was 10 mM HEPES (pH 7.0), that for the class B ␤-lactamase was 25 mM HEPES (pH 7.5) with 100 M ZnSO 4 ; that for the DD-peptidase of Streptomyces sp. strain R61 was 10 mM sodium phosphate (pH 7.0) with 0.4 M NaCl, and that for the enzyme of Streptomyces sp. strain K15 was 25 mM sodium phosphate (pH 7.2) with 4 M dithiothreitol. Dilutions of the ␤-lactamases below a concentration of 0.1 mg/ml were made with buffer solutions containing 0.1 mg of bovine serum albumin per ml.
Hydrolysis of Lek 156 and Lek 157 was directly monitored at 310 nm by using changes in ε M (⌬ε M ) values of Ϫ1,850 and Ϫ1,350 M Ϫ1 cm
Ϫ1
, respectively. Nitrocefin was used as the reporter substrate in all experiments performed with ␤-lactamases. The absorbance was monitored at 482 nm, and the conditions were chosen such that the level of use of nitrocefin was below 10%. The concentration of nitrocefin (100 M) was such that the correction factor ␣ (see equation 5 in the Evaluation of the Kinetic Results section) was ϳ5.3 for the ␤-lactamase of E. cloacae 908R (K m of the reporter substrate [K m,S ] ϭ 23 Ϯ 2 M), ϳ2.8 for the TEM-1 ␤-lactamase (K m,S ϭ 55 Ϯ 5 M), and ϳ7.7 for the OXA-10 ␤-lactamase (K m,S ϭ 15 Ϯ 1 M), so that no large errors were introduced [15] . These K m,S values were derived from the analysis of complete hydrolysis time courses obtained with nitrocefin and the respective enzymes (15) .
The reporter substrates for the Streptomyces sp. strain K15 and R61 DDpeptidases were 400 M S 2 x and S 2 d, respectively, and hydrolysis was monitored in the presence of a chemical agent that reacts with thiol groups (49). 5,5Ј-Dithionitrobenzoic acid was used at 1.4 mM, and the absorbance was monitored at 412 nm. Protection by the reporter substrates did not have to be considered, since with both enzymes [S] was ϽϽK m (i.e., ␣ was equal to 1), where [S] is the concentration of the reporter substrate.
With the Streptomyces sp. strain R61 DD-peptidase, inactivation was also monitored by measuring the quenching of fluorescence intensity ( for excitation, 280 nm, for emission, 320 nm), as described by Frère et al. (22) .
UV and visible spectroscopic measurements were performed on a Beckman DU-8 spectrophotometer. Intrinsic fluorescence emission was recorded with a Perkin-Elmer LS50 spectrometer.
Data analysis. Kinetic data were fitted by linear or nonlinear regression with the program GraFit (32) .
Evaluation of the kinetic results. (i) Kinetic models. Both active-site serine ␤-lactamases and DD-peptidases generally hydrolyze their substrates according to a simple three-step acylation-deacylation pathway (23, 35, 48) , as follows:
where E is the enzyme, C is the antibiotic, and P(s) is the inactive degradation product(s) of the antibiotic and where k 2 and k 3 are the first-order rate constants for acylation and deacylation, respectively. If k 3 is very low or equal to zero, the antibiotic becomes a transient or irreversible inactivator (model 1b) (37, 39) . EC is the noncovalent Henri-Michaelis complex, and EC ‫ء‬ is the acyl-enzyme. In most cases, the reaction can be quantitatively described by the Henri-Michaelis-
, and the steady-state parameters are as follows:
and
where
Equation 4 shows that the apparent second-order rate constant for substrate hydrolysis, k cat /K m (also called the specificity constant), corresponds to the apparent second-order rate constant for acyl-enzyme formation (k 2 /KЈ).
More complex interactions involving rearrangement of the initially formed acyl-enzyme (EC ‫ء‬ ) have been encountered (model 2a):
where EC** is a second acyl-enzyme, in which the antibiotic moiety has rearranged. Note that this inactivated species might also rearrange back to EC ‫ء‬ (k Ϫ4 0). It is, however, usually impossible to distinguish between the k Ϫ4 and the k 5 steps (because P3PЈ), and it is arbitrarily assumed that k Ϫ4 is equal to 0 (36, 40) . between active-site serine ␤-lactamases and some cephalosporin-like compounds exhibiting a leaving group on C-3Ј. Models 2a, 2aЈ, and 2b were used to characterize the interactions of various enzymes with ␤-lactamase-stable compounds (37, 39, 40) . With the class A ␤-lactamases of Actinomadura sp. strain R39 and Streptomyces albus G, both ␤-iodopenicillanate (21) and sulbactam (36) seemed to react according to model 2c. An even more complex mechanism was suggested to describe the interaction between both clavulanate (10, 11) and sulbactam (3, 4) and the TEM-2 ␤-lactamase. This model involves a third branch, which accounts for additional intramolecular events that lead to irreversible inactivation of the enzyme (5, 31) .
(ii) Determination of kinetic parameters. Progressive inactivation of the Streptomyces sp. strain K15 and R61 DD-peptidases was monitored discontinuously by measuring the residual activity either after increasing periods of time at fixed inhibitor concentrations or after a fixed period of time at different inhibitor concentrations (30) , to give pseudo-first-order rate constants for inactivation (k i ). With ␤-lactamases, inactivation can be monitored continuously with a reporter substrate (15) . When inactivation is complete, a steady state (v ss ϭ 0) is eventually reached and the pseudo-first-order inactivation rate constant, k i , can be computed (15) . For all the models described above, with the exception of models 2a and 2c, the value of k i is given by
where k r takes the values of zero for models 1b and 2b, the value of k 3 for model 1a, and the value of k 5 for model 2aЈ. The correction factor ␣ equal to 1 ϩ [S]/K m,S accounts for the protection of the enzyme by the reporter substrate (S).
Values of k i were measured at various carbapenem concentrations [C], and when k i exhibited a hyperbolic variation with [C] the individual values of k 2 and KЈ could be computed by nonlinear regression. When KЈ was too high, only the ratio k 2 /KЈ could be obtained.
When k 3 (model 1a) or k 5 (model 2aЈ) is not negligible, inactivation is incomplete and the reporter substrate utilization reaches a steady state (v ss 0). Here, the K m value for the carbapenem (K m,C ) can be computed from
which takes into account the competition between the two substrates at the steady state. v 0 is the initial rate of hydrolysis of the reporter substrate in the absence of carbapenem. Much more complex kinetics prevail for models 2a and 2c, which describe branched pathway mechanisms. In both cases, the ratio of the k 3 and k 4 rate constants (k 3 /k 4 ), Waley's partition ratio (47) , represents the ratio of the number of productive turnovers to those reactions that lead to irreversible enzyme inactivation. As described previously (36) Provided that k 3 is Ͼ Ͼk 4 , conditions can be chosen in which one branch of the pathway has negligible effects on the other (21) . Thus, under conditions in which hydrolysis can be neglected
, enzyme inactivation is also characterized by a pseudo-first-order inactivation rate constant (k i ), which can be measured as described above for the linear pathways. In the case of model 2c, the following equation applies:
and thus
In this mechanism, (k i ) lim is a first-order rate constant characterizing the rate of the inactivation process at saturating inactivator concentrations. An even more complicated value of k i is given for model 2a by equation 13:
In both models 2a and 2c, the steady-state parameters k cat and K m can be determined by initial rate measurements (k cat ) and competitive inhibition experiments (K m ), performed rapidly before the inactivation process becomes detectable (21) .
RESULTS
Class A ␤-lactamases: NmcA and TEM-1. Both Lek 156 and Lek 157 are readily hydrolyzed by the NmcA enzyme, and the UV spectra of the products (P) are the same whether they are obtained with sodium hydroxide, the NmcA and TEM-1 enzymes, or the Zn 2ϩ -containing Bacillus cereus II ␤-lactamase as hydrolytic agents (Fig. 2) . Hydrolysis of the two compounds was monitored at 310 nm to avoid protein absorption at lower wavelengths. A major absorbance decrease (⌬ε M , Ϫ1,850 and Ϫ1,350 M Ϫ1 cm Ϫ1 for Lek 156 and Lek 157, respectively) is followed by a very slow and partial recovery in intensity (⌬ε M Ϸ 1,000 M Ϫ1 cm Ϫ1 for both compounds; Fig. 2A ). This probably arises from the formation of the rearrangement product shown in Fig. 1C , in which the methoxy group of the cyclohexane ring has been eliminated. Indeed, mass spectrometry experiments (M. Vilar, B. Turk, and T. Solmajer, unpublished data) suggest that the major product in these hydrolysis experiments is the 3-(1-carboxy-1-propenyl)-3Ј, 4, 5, 6-tetrahydro-3H-isoindole-1-carboxylate (Lek 1A) rearrangement product (Fig. 1C) , which lacks the methoxy group. In addition, it is reasonable to assume that the normal ␦-2 pyrroline intermediate covalently rearranges into the tautomeric and thermodynamically more stable ␦-1 pyrroline (31) .
Incubation of NmcA with initial Lek 156 and Lek 157 concentrations up to 20,000 times that of the enzyme did not lead to inactivation, and the kinetic parameters k cat and K m are given in Tables 2 and 3 . The very low K m values were measured as K i with 100 M nitrocefin as the substrate (41) (Fig. 3) , whereas the k cat values were derived from initial rate measurements at saturating concentrations (
The spectral changes shown in Fig. 2A suggest that the rearrangement process which follows the opening of the ␤-lactam ring is slow. As a consequence, it probably occurs in solution, after hydrolysis of the acyl-enzyme complex, in which case model 1a accounts for the interaction between NmcA and both Lek compounds.
With (Tables 2 and 3) .
Under conditions in which the horizontal branch of model 2c is observed ([C] 0 /[E] 0 Ͻ k 3 /k 4 ), the hydrolysis of both compounds by TEM-1 is also characterized by a significant absorbance decrease at 310 nm, followed by a very slow and partial recovery of intensity, as observed with NmcA. In addition, the difference in the spectra of the inactivated acyl-enzyme species and the starting compound (Lek 156 or Lek 157) indicates clear similarities between the spectrum of the complex (EC**) and that of the rearranged hydrolyzed compound (Fig. 2B) . These results suggest that the inactivated species (EC**) contains a rearranged carbapenem molecule with properties similar to those of the final hydrolysis product (Fig. 1C) . This leads to the conclusion that rearrangement of the opened ␤-lactam molecule occurs much faster in the enzyme active-site cavity than in solution (Fig. 2A) .
The Class C ␤-lactamase: E. cloacae 908R. The reaction observed with the E. cloacae 908R enzyme appears to be more simple. The two carbapenems form long-lived (t 1/2 Ͼ 1 h) inactivated complexes with the ␤-lactamase, and titration measurements indicate that, in both cases, complete inactivation occurs at an equimolar (1:1) ratio. Thus, the interaction between Lek 156 or Lek 157 and the ␤-lactamase from E. cloacae 908R can be interpreted on the basis of a linear pathway. The presence of a putative leaving group at the C-3Ј positions of these compounds suggests that the accumulated acyl-enzymes are the rearranged adduct (EC**) (model 2aЈ). The difference spectra (data not shown) between the inactivated species and the starting compounds are closely similar to those shown in Fig. 2B . Thus, the inactivated species obtained with the E. cloacae 908R ␤-lactamase probably involves the rearranged carbapenem molecules. (Fig. 4C) . . This value is about 2 orders of magnitude lower than that obtained for k 2 by the reporter substrate method. This apparent discrepancy can be explained on the basis of model 2aЈ. In this model, the inactivation of the enzyme observed by the reporter substrate method is due to the accumulation of the first acyl-enzyme species (EC ‫ء‬ ), whereas the enzyme inactivation followed by direct hydrolysis of the compound results from the accumulation of the second acylenzyme species (EC**). Thus, the values obtained by the two methods correspond to different rate constants, i.e., k 2 (ϳ0.4 s Ϫ1 ) and k 4 (ϳ0.002 s Ϫ1 ). In addition, the difference spectra between the inactivated species and Lek 156 and Lek 157, which are very similar to that obtained with Tem-1 (Fig. 2B) , indicate that the rearranged hydrolyzed compounds are bound at the active-site cavity (EC**). These results show that model 2aЈ adequately describes the interaction between the E. cloacae 908R ␤-lactamase and the two carbapenem molecules.
Finally, the recovery of activity after partial (80 to 95%) inactivation of the enzyme yielded k r (k 5 ) values of (1.5 Ϯ 0.1) ϫ 10 Ϫ4 and (0.4 Ϯ 0.07) ϫ 10 Ϫ4 s Ϫ1 for Lek 156 (Fig. 5 ) and Lek 157, respectively. The values of the kinetic parameters determined with the E. cloacae 908R ␤-lactamase are given in Tables 2 and 3 .
Although the inactivation pathways were not studied in detail, it could easily be shown that the extended-spectrum, plasmid-encoded ACT-1 and CMY-1 class C ␤-lactamases were inactivated after 5 min of contact with 1 M Lek 157, while 20 M Lek 157 was necessary for inactivation of MIR-1.
Class D ␤-lactamase: OXA-10. As with the TEM-1 ␤-lactamase, OXA-10 reacts according to a branched pathway with both compounds. Although complete enzyme inactivation is achieved at much lower [C] (Tables 2 and 3) show that the two carbapenems are hydrolyzed very efficiently by the BcII enzyme. In the absence of any indication of a more complex situation, the simple Henri-Michaelis model was used, and initial rate measurements at various substrate concentrations allowed the individual k cat and K m values to be determined. Kinetics similar to those of the NmcA enzyme are observed by monitoring the change in absorbance at 310 nm.
DD-Peptidases of Streptomyces sp. strains R61 and K15. The interactions between the two DD-peptidases and Lek 156 and Lek 157 can be analyzed on the basis of a simple linear pathway (model 1a). Due to the very slow (t 1/2 Ͼ 4 h) deacylation process, however, the rearrangement of the opened ␤-lactam compounds probably occurs at the level of the acyl-enzyme (EC* 3 EC**), in which case model 2aЈ provides a better description of the phenomenon.
The kinetic parameters are listed in Table 4 . In inactivation experiments with the Streptomyces sp. strain K15 and R61 DD-peptidases by using S 2 x as the reporter substrate or fluorescence quenching, respectively, only the k 2 /KЈ values could be determined. Reactivation experiments (using S 2 x and S 2 d for the K15 and R61 enzymes, respectively) allowed the deacylation rate constants (k 3 ) to be calculated.
In vitro susceptibility tests. Lek 156 and Lek 157 had no effect at concentrations up to 284 g/ml. The MICs (Table 5) of ampicillin were significantly reduced by the presence of 30 g of Lek 157 per ml or 10 g of tazobactam per ml. The presence of Lek 156 also decreased the MIC of ampicillin, but with a lesser efficiency. However, it should be noted that Lek 156 was unstable even in pure phosphate buffer (pH 7). Under these conditions, a UV and visible spectrum indicated that more than 50% of the compounds was degraded after 24 h at 20°C.
DISCUSSION
Both tricyclic carbapenem molecules tested in the present study, Lek 156 and Lek 157, are very efficient inactivators of the E. cloacae 908R class C ␤-lactamase. With this enzyme, the reaction pathway appears to be linear (model 2aЈ) due to negligible hydrolysis of the first covalent adduct (k 3 ϽϽ k 4 ) and a very low k 5 value (1.5 ϫ 10 Ϫ4 s Ϫ1 or less). At saturating concentrations, the enzyme is rapidly inactivated (k 2 /KЈ Ϸ 2 ϫ 10 4 to 4 ϫ 10 4 M Ϫ1 s Ϫ1 ), and the resulting species, EC**, although not completely stable, displays very low turnover values (t 1/2 Ϸ 1 to 5 h). Preliminary experiments also indicate that both compounds efficiently inactivate various extended-spectrum class C ␤-lactamases. It is interesting that BRL 42715 (6, 17, 40) , which is also a good inactivator of class C enzymes, shares structural characteristics with the compounds studied in the present work.
In agreement with these observations, Lek 157 significantly reduced the MIC of ampicillin for E. cloacae P99, which overproduces a class C ␤-lactamase. The lesser decrease in the MIC observed with Lek 156 probably results from the intrinsic instability of this compound.
The NmcA ␤-lactamase (class A) has been chosen for its unusual catalytic properties (34) . It is a very broad spectrum enzyme, hydrolyzing efficiently not only classical penams and cephems but also a wide range of ␤-lactam molecules usually considered resistant to class A ␤-lactamases. k ϩ4 ). Most interestingly, the rearranged adducts (EC**) are found to be very stable (t 1/2 Ͼ 4 h). A similar mechanism is observed with the class D enzyme (OXA-10). In this case, however, the ratio between the number of productive turnovers and reactions that lead to enzyme inactivation (i.e., the partition ratio k 3 /k 4 ) is quite low, and the enzyme is completely inactivated on a shorter time scale (t 1/2 Ϸ 2 to 4 min). Furthermore, the inactivated species (EC**), is not fully stable, and hydrolysis of the rearranged adduct (EC**) is observed (k 5 0; t 1/2 Ϸ 10 to 20 min).
Like all other known carbapenems, which are usually only very poorly hydrolyzed by the active-site serine ␤-lactamases (37), Lek 156 and Lek 157 are readily hydrolyzed by the Zn 2ϩ -containing class B enzyme (18) . With the two compounds, both the k cat /K m (Ն5 ϫ 10 6 M Ϫ1 s Ϫ1 ) and the k cat (Ն700 s Ϫ1 ) values are remarkably high, which confirms the high degree of catalytic efficiency of this enzyme (18) .
With the representative enzymes considered in the present work, the spectral properties of the final hydrolysis products are identical and correspond to Lek 1A (Fig. 1C) , which is also obtained after sodium hydroxide hydrolysis. It is probable that a very slow rearrangement of the primary hydrolysis product, i.e., elimination of the methoxy group of the cyclohexane ring and tautomerization to the ␦-2 pyrroline, occurs after its release from the enzyme. These two events are characterized by significant changes in the molecular extinction coefficient value of the molecules at 310 nm, i.e., ca. Ϫ1,500 M Ϫ1 cm Ϫ1 and ca. ϩ 1,000 M Ϫ1 cm Ϫ1 for the ␤-lactamase-catalyzed opening of the ␤-lactam ring and the spontaneous rearrangement of the cleaved ␤-lactam, respectively. It appears, however, that the rearrangement takes place much faster when the opened ␤-lactam is trapped as a stable acyl-enzyme species, as is the case with the TEM-1, E. cloacae 908R, and OXA-10 enzymes.
The results indicate that both compounds are very poor acylating agents (k 2 /KЈ ϭ 0.5 to 50 M Ϫ1 s
Ϫ1
) for the two model DD-peptidases. With imipenem, a semisynthetic carbapenem antibiotic, the k 2 /KЈ values have been estimated to be 1,000 M Ϫ1 s Ϫ1 (for the Streptomyces sp. strain R61 enzyme [30] ) and 100 to 200 M Ϫ1 s Ϫ1 (for the Streptomyces sp. strain K15 enzyme [33] ). Imipenem is, however, a broad-spectrum antibiotic which very efficiently inactivates some of the essential penicillin-binding proteins of the pathogenic strains and is therefore often used as a last resort for patients in intensive care units. Thus, the intrinsic antibacterial activities of the new Lek carbapenem antibiotics, which have not yet been tested in vivo, cannot be predicted on the basis of the behaviors of the two DD-peptidases tested in the present study.
The present survey of the interaction between different ␤-lactamases and two novel enantiomeric carbapenem molecules confirms the very different behaviors of the enzymes. Although both compounds are readily hydrolyzed by the so-called carbapenem-hydrolyzing ␤-lactamases of class A (NmcA) and class B (BcII), they are efficient inactivators of the "classical" active-site serine ␤-lactamases. This is a quite unusual, specific, and interesting property, since most other mechanism-based inactivators of active-site serine enzymes (e.g., clavulanic acid and sulbactam) generally exhibit rather poor activity against class C enzymes. These enzymes may be associated with resistance profiles that include virtually all ␤-lactam antibiotics (7, 35) , and the recent discovery of many new plasmid-mediated forms of genes encoding class C enzymes has now been recognized as a serious threat. Our kinetic data therefore suggest that further development of the tricyclic carbapenem compounds could be of clinical interest. 
